Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes and Circulating Biomarkers Summit 2013

Karri Bradley's Biography



Karri Bradley, Partner, Klarquist Sparkman, LLP

Dr. Bradley is a partner at Klarquist Sparkman, LLP in Portland, Oregon. She specializes in the preparation and prosecution of U.S. and International patent applications, and advises clients about patent portfolio management, freedom-to-operate, and strategic product development. Her practice emphasis is on preparing medical, chemical, biotechnical, and pharmaceutical patent applications, including applications relating to biologic drugs and their use, and diagnostic methods involving DNA expression profiling. Dr. Bradley has a strong multidisciplinary background with technical expertise in molecular biology, cell biology, structural biology, physiology, and pharmacology.

Karri Bradley Image

Biomarker IP after Prometheus: Patenting the Unpatentable

Friday, 13 September 2013 at 16:45

Add to Calendar ▼2013-09-13 16:45:002013-09-13 17:45:00Europe/LondonBiomarker IP after Prometheus: Patenting the UnpatentableExosomes and Circulating Biomarkers Summit 2013 in San Diego, CASan Diego, CASELECTBIOenquiries@selectbiosciences.com

In this tag-team presentation, two IP lawyers will discuss the latest trends in this evolving field:

The Supreme Court decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc. shifted the biomarker IP landscape by raising the bar to obtain meaningful patent protection for diagnostic methods involving biomarker detection.  We will review recent developments in patent law concerning diagnostic method claims, and the approaches we are currently using to successfully address the Prometheus standard.


Add to Calendar ▼2013-09-12 00:00:002013-09-13 00:00:00Europe/LondonExosomes and Circulating Biomarkers Summit 2013Exosomes and Circulating Biomarkers Summit 2013 in San Diego, CASan Diego, CASELECTBIOenquiries@selectbiosciences.com